A recent study has shown that mothers who have children at the age of 33 or after are twice as likely to live longer than women who stop childbearing by the age of 29....
A simple blood test that can predict the likelihood of developing non-inherited breast cancer could be developed, following research into the epigenetics of the disease...
A combination of two gene-targeting drugs significantly increases the lung function of cystic fibrosis patients, a clinical trial shows....
An Australian fertility company has seen the price of its shares rise on the first day of its public listing on the stock market....
The age of sperm donors has no impact on the chances of having a baby via IVF and donor insemination, a study has found...
A stem cell therapy that is highly successful at keeping race horses in the fast lane is to be trialled in humans for the treatment of Achilles tendinopathy...
Genetic disorders are often so rare that patients never receive a genetic, or even a clinical, diagnosis. Now an everyday photo may be all that's needed, using a newly developed computer program to analyse facial structures...
Surprisingly, the theme of kinship is not explored in detail during this show. Instead, the speakers skirt around the topic and set the scene without going any further...
Stay up-to-date on all the latest developments in the fields of human fertility and genomics. And be the first to hear about upcoming events and other announcements.
Comment
Patient organisations challenge process for accessing orphan and ultra orphan medicines in Wales
by Emma Hughes
In Wales, the subject of access to medicines has recently been in the spotlight. We are calling on the National Assembly to review the use of the 'exceptionality' rule in determining whether a patient can access a treatment through the IPFR process...
Podcast: Risk Management - Breast Cancer, Business and Patents
by James Brooks
Does the pharmaceutical and biotech industry's profit motive actually pervert rather than inspire innovation and the hunt for new therapies? Is the patent system well suited to a new life sciences landscape including stem cell and gene therapies?...